Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Option Activity Rollforward) (Details)

v2.4.0.8
Stockholders' Equity (Option Activity Rollforward) (Details) (USD $)
 3 Months Ended 3 Months Ended
Sep. 30, 2014
Jun. 30, 2014
Sep. 30, 2014
Awards assumed from SGI spin-off
Sep. 30, 2014
Stock Options
Sep. 30, 2013
Stock Options
Sep. 30, 2014
Stock Options
Former Parent SGI Plans
Sep. 30, 2013
Stock Options
Former Parent SGI Plans
Sep. 30, 2014
Stock Options
Awards assumed from SGI spin-off
Sep. 30, 2013
Stock Options
Awards assumed from SGI spin-off
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Share-based compensation expense       $ 39,600 $ 0 $ 0 $ 0 $ 39,600 $ 0
Total compensation cost not yet recognized     432,000            
Period for recognition of nonvested awards       3 years 26 days          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]                  
Options, beginning balance 230,787                
Granted through stock option plan 0                
Exercised 0                
Cancellations, expirations and forfeitures (660)                
Options, ending balance 230,127                
Options, Shares exercisable at end of period 134,242                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]                  
Weighted Average Exercise Price, beginning balance (in dollars per share) $ 10.00                
Weighted Average Exercise Price, Granted (in dollars per share) $ 0.00                
Weighted Average Exercise Price, Exercised (in dollars per share) $ 0.00                
Weighted Average Exercise Price, Cancellations, expirations and forfeitures (in dollars per share) $ 48.02                
Weighted Average Exercise Price, ending balance (in dollars per share) $ 9.89                
Weighted Average Exercise Price, Shares exercisable at end of period $ 11.00                
Intrinsic value, balance 446,000 407,000              
Intrinsic Value, Shares exercisable at end of period $ 155,000                
Weighted Average per share Grant Date Fair Value, beginning balance (in dollars per share) $ 5.98                
Weighted Average per share Grant Date Fair Value, ending balance (in dollars per share) $ 6.00                
Weighted Average per share Grant Date Fair Value, Shares exercisable at end of period (in dollars per share) $ 5.80